Comparison of the clinical impact of 2-[(18)F]FDG-PET and cerebrospinal fluid biomarkers in patients suspected of Alzheimer’s disease

BACKGROUND: The two biomarkers 2-[(18)F]FDG-PET and cerebrospinal fluid biomarkers are both recommended to support the diagnosis of Alzheimer’s disease. However, there is a lack of knowledge for the comparison of the two biomarkers in a routine clinical setting. OBJECTIVE: The aim was to compare the...

Descripción completa

Detalles Bibliográficos
Autores principales: Gjerum, Le, Andersen, Birgitte Bo, Bruun, Marie, Simonsen, Anja Hviid, Henriksen, Otto Mølby, Law, Ian, Hasselbalch, Steen Gregers, Frederiksen, Kristian Steen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7954298/
https://www.ncbi.nlm.nih.gov/pubmed/33711065
http://dx.doi.org/10.1371/journal.pone.0248413

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7954298/
https://www.ncbi.nlm.nih.gov/pubmed/33711065
http://dx.doi.org/10.1371/journal.pone.0248413

Ejemplares similares